A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with [alpha]1-antitrypsin deficiency

• Published in: Hepatology (Baltimore, Md.) Vol. 52; no. 3; p. 1078
• Main Authors: Miranda, Elena, Perez, Juan, Ekeowa, Ugo I, Hadzic, Nedim, Kalsheker, Noor, Gooptu, Bibek, Portmann, Bernard, Belorgey, Didier, Hill, Marian, Chambers, Susan, Teckman, Jeff, Alexander, Graeme J, Marciniak, Stefan J, Lomas, David A
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc 01.09.2010
• Subjects: Hepatology; Liver diseases; Polymers
• ISSN: 0270-9139; 1527-3350
• DOI: 10.1002/hep.23760

Alpha1-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency allele (Glu342Lys) causes the protein to undergo a conformational transition and form ordered polymers that are retained within hepatocytes. This causes neonatal hepatitis, cirrhosis, and hepatocellular carcinoma. We have developed a conformation-specific monoclonal antibody (2C1) that recognizes the pathological polymers formed by [alpha]1-antitrypsin. This antibody was used to characterize the Z variant and a novel shutter domain mutant (His334Asp; [alpha]1-antitrypsin King's) identified in a 6-week-old boy who presented with prolonged jaundice. His334Asp [alpha]1-antitrypsin rapidly forms polymers that accumulate within the endoplasmic reticulum and show delayed secretion when compared to the wild-type M [alpha]1-antitrypsin. The 2C1 antibody recognizes polymers formed by Z and His334Asp [alpha]1-antitrypsin despite the mutations directing their effects on different parts of the protein. This antibody also recognized polymers formed by the Siiyama (Ser53Phe) and Brescia (Gly225Arg) mutants, which also mediate their effects on the shutter region of [alpha]1-antitrypsin. Conclusion: Z and shutter domain mutants of [alpha]1-antitrypsin form polymers with a shared epitope and so are likely to have a similar structure. HEPATOLOGY 2010